In a phase III trial, pre-op MRI did not reduce locoregional recurrences or improve survival among women with early-stage ...

Patients with stage I or II hormone receptor-negative breast cancer do not benefit from preoperative breast MRI, according to ...

When it comes to your health, how far would you go to find out what's wrong? For one woman, time was of the essence when it ...

Use of preoperative MRI is variable across practices, but "there's really no clinical benefit," she said. "We have for a very ...

Early MRI predicts pathologic complete response and long-term outcomes in TNBC patients receiving pembrolizumab.

MRIs are an effective diagnostic tool for pituitary tumors. Although MRI scans can miss very small tumors, newer machines are better equipped to detect them. Most pituitary tumors are noncancerous, or ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional ...

Preoperative breast MRI did not improve LRR, DRFR, or OS outcomes in early-stage breast cancer patients. The trial involved ...

The company said Monday interim data showed that for 92% of patients in the trial, the imaging agent RAD 101 achieved concordance with MRI imaging, the primary endpoint for the trial. The trial also ...

A large observational study using data from the Breast Cancer Surveillance Consortium suggested that supplemental MRI with or ...